Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer

Shama Prasada Kabekkodu, Sanjiban Chakrabarty, Supriti Ghosh, Angela Brand, Kapaettu Satyamoorthy

Research output: Contribution to journalReview articlepeer-review

19 Citations (Scopus)


Epigenomics encompasses the study of genome-wide changes in DNA methylation, histone modifications and noncoding RNAs leading to altered transcription, chromatin structure, and posttranscription RNA processing, respectively, resulting in an altered rate of gene expression. The role of epigenetic modifications facilitating human diseases is well established. Previous studies have identified histone and cytosine code during normal and pathological conditions with special emphasis on how these modifications regulate transcriptional events. Recent studies have also mapped these epigenetic modification and pathways leading to carcinogenesis. Discovery of drugs that target proteins/enzymes in the epigenetic pathways may provide better therapeutic opportunities, and identification of such modulators for DNA methylation, histone modifications, and expression of noncoding RNAs for several cancer types is underway. In this review, we provide a detailed description of recent developments in the field of epigenetics and its impact on personalized medicine to manage cervical cancer.

Original languageEnglish
Pages (from-to)100-115
Number of pages16
JournalPublic Health Genomics
Issue number2
Publication statusPublished - 01-09-2017

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Genetics(clinical)


Dive into the research topics of 'Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer'. Together they form a unique fingerprint.

Cite this